Company news

Bio-Techne Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

May 25, 2022

Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder Cancer Test

May 11, 2022

Bio-Techne releases third quarter fiscal 2022 results

May 3, 2022

Bio-Techne to host conference call on May 4, 2022, to announce third quarter 2022 financial results

April 12, 2022

Bio-Techne and Cygnus Technologies, part of Maravai LifeSciences, introduce new Simple Plex HEK 293 HCP 3G immunoassay

April 11, 2022

Bio-Techne announces exclusive development and license agreement with Thermo Fisher Scientific for ExoTRU® kidney transplant rejection assay

February 21, 2022

Bio-Techne announces publication of new data demonstrating ExoDx prostate test correlation with post-prostatectomy pathology outcomes

February 13, 2022

Bio-Techne releases second quarter fiscal 2022 results

January 31, 2022

Bio-Techne announces commercial release of high sensitivity fluorescent detection Stellar nir / IR™ Modules for Jess automated western blotting system

January 17, 2022

Bio-Techne to host conference call on February 1, 2022 to announce second quarter 2022 financial results

January 16, 2022

Bio-Techne announces updated presentation time at the j.p. morgan healthcare conference

January 6, 2022

Bio-Techne announces appointment of Brenda Everson as svp human resources

December 26, 2021

Bio-Techne announces appointment of will Geist as President, Protein Sciences Segment

December 20, 2021

Bio-Techne announces future Wilson Wolf purchase agreement

December 13, 2021

Bio-Techne Announces Publication of Lateral Flow Technology Proof-of-Concept Data

December 7, 2021

Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility

November 2, 2021

Bio-Techne Releases First Quarter Fiscal 2022 Results

November 1, 2021

Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

October 12, 2021

Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results

October 10, 2021

Bio-Techne Launches ExCellerate™ iPSC Expansion Medium

September 13, 2021

Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis

September 7, 2021

Bio-Techne Releases Fourth Quarter Fiscal 2021 Results

August 4, 2021

Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2

August 3, 2021

Bio-Techne Announces 2021 Investor Day and Webcast

August 2, 2021

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

July 27, 2021

Bio-Techne Announces Commercial Release of RNAscope™ HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples.

July 26, 2021

Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results

July 12, 2021

Bio-techne Announces Opening Of New Ireland Facility

June 27, 2021

Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies

June 23, 2021

Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities

June 9, 2021

Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium

June 7, 2021

Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications

May 17, 2021

Bio-Techne Releases Third Quarter Fiscal 2021 Results

May 5, 2021

Bio-Techne and 908 Devices Announce Joint Collaboration

May 3, 2021

Bio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

April 26, 2021

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

April 14, 2021

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

April 13, 2021

Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

April 7, 2021

Bio-Techne Completes Acquisition of Asuragen, Inc.

April 5, 2021

Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures

March 28, 2021

Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb

March 25, 2021

Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test

March 22, 2021

Bio-Techne Announces ISO 9001: 2015 Certification for its Bristol Manufacturing Facility.

March 14, 2021

Bio-Techne Announces ExoTRU Kidney Transplant Rejection Assay Data Publication

March 7, 2021

Bio-Techne to Acquire Asuragen

March 2, 2021

Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana

February 28, 2021

Bio-Techne Announces ISO 14001: 2015 Certification for the EMEA region of Bio-Techne.

February 24, 2021

Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster™ for the development of Luminary's CAR-T cell therapies

February 22, 2021

Bio-Techne Announces Paper Publication In Annals Of Oncology

February 10, 2021

Bio-Techne Announces Expanded Simple Plex Immunoassay Cartridge Portfolio

February 2, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.